CMTx Biotech

Cm Tx Biotech

Biotechnology, 25 Health Sciences Drive, Stony Brook, New York, 07105, United States, 1-10 Employees

cmtxbiotech.com

  • LinkedIn

phone no Phone Number: 63********

Who is CMTX BIOTECH

CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseas...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CMTX BIOTECH

CMTx Biotech Org Chart and Mapping

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding CMTx Biotech

Answer: CMTx Biotech's headquarters are located at 25 Health Sciences Drive, Stony Brook, New York, 07105, United States

Answer: CMTx Biotech's phone number is 63********

Answer: CMTx Biotech's official website is https://cmtxbiotech.com

Answer: CMTx Biotech's revenue is $5 Million to $10 Million

Answer: CMTx Biotech's SIC: 2836

Answer: CMTx Biotech's NAICS: 541714

Answer: CMTx Biotech has 1-10 employees

Answer: CMTx Biotech is in Biotechnology

Answer: CMTx Biotech contact info: Phone number: 63******** Website: https://cmtxbiotech.com

Answer: CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseases with high unmet needs. The companys lead drug candidate is a clinical-stage, orally-administered small molecule (incyclinide / CMT-3 / COL-3) for the treatment of hospitalized sepsis patients at risk of septic shock, multiple organ dysfunction syndrome (MODS) and acute respiratory distress syndrome (ARDS), including from SARS-CoV-2 infection (COVID-19) and other infectious diseases. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of sepsis/ARDS/MODS across multiple species (rats, mice, pigs, sheep). It has also been evaluated in over 450 patients across eleven Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of diseases with high unmet need.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access